The U.S. clinical trial packaging market is expected to grow from USD 1.15 billion in 2026 to about USD 2.7 billion by 2035, registering a CAGR of 9.9% during this period. This growth is mainly driven by the rising number of chronic illnesses such as cancer, diabetes, and heart diseases, as well as the emergence of new infectious diseases like COVID-19. These health challenges are increasing the need for more clinical trials, which in turn boosts the demand for specialized packaging used to safely store and transport trial medicines, vaccines, and treatments.